London Stock Exchange Considers Sale of Italian Unit To Secure Refinitiv Deal

London Stock Exchange Group (LSE) took a key step toward gaining regulatory approval for its US$15 billion acquisition of financial-data company Refinitiv Holdings by entering into exclusive talks for the sale of its Italian exchange operator, reported The Wall Street Journal.
LSE announced Friday, September 18, it is in discussions to sell Borsa Italiana Group to a consortium comprising pan-European rival Euronext NV, an investment arm of the Italian government, and Intesa Sanpaolo for an undisclosed amount.
The UK-based exchange operator indicated in July that it might sell Borsa Italiana amid efforts to secure approval from Europe’s antitrust regulator for the much bigger Refinitiv deal. The European Commission has raised concerns that the tie-up could give the combined entity undue power over European government-bond trading, among other areas.
But the sale of Borsa Italiana, which includes bond-trading platform MTS SpA, is expected to reduce that potential sway over the market, bankers and analysts have said.
Full Content: Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Rumble Adds David Boies to Legal Team in $2 Billion Antitrust Battle with Google
May 14, 2025 by
CPI
China Summons Delivery Giants Over Unfair Competition Concerns
May 13, 2025 by
CPI
Judge Orders Sanctions Against Missouri for Noncompliance in Price-Fixing Probe
May 13, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas